<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30537075</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-8749</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Developmental medicine and child neurology</Title><ISOAbbreviation>Dev Med Child Neurol</ISOAbbreviation></Journal><ArticleTitle>Magnetic resonance imaging in enterovirus-71, myelin oligodendrocyte glycoprotein antibody, aquaporin-4 antibody, and multiple sclerosis-associated myelitis in children.</ArticleTitle><Pagination><StartPage>1108</StartPage><EndPage>1116</EndPage><MedlinePgn>1108-1116</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/dmcn.14114</ELocationID><Abstract><AbstractText Label="AIM">We used magnetic resonance imaging (MRI) to compare the neuroimaging of children with their first episode of clinical enterovirus 71-associated transverse myelitis (EV71-TM), myelin oligodendrocyte glycoprotein antibody positive transverse myelitis (MOG-TM), aquaporin-4 antibody positive transverse myelitis (AQP4-TM), transverse myelitis in multiple sclerosis (MS-TM), and unclassified transverse myelitis (UNC-TM).</AbstractText><AbstractText Label="METHOD">We performed a retrospective blinded radiological assessment and compared the neuroimaging of 52 children (32 females, 20 males; mean age 9y 8mo, SD 5y 5mo, range 5mo-17y) presenting with their first episode of myelitis caused by EV71-TM (n=11), MOG-TM (n=10), AQP4-TM (n=9), MS-TM (n=13), and UNC-TM (n=9).</AbstractText><AbstractText Label="RESULTS">In the EV71-TM group, lesions were distributed throughout the cord and enhancement of nerve roots (ventral and dorsal) was common. The MOG-TM group had lesions distributed throughout the cord and most commonly longitudinally extensive transverse myelitis and lesions involving the grey matter alone on axial scans. The AQP4-TM group had lesions distributed in the cervicothoracic spine, cavitation, and contrast enhancing lesions. All patients with AQP4-TM had an abnormal brain MRI scan. The MS-TM group characteristically had multiple short segment lesions of the cord involving the cervicothoracic spine. The UNC-TM group did not have distinctive spinal MRI findings but had a relative paucity of lesions on their brain MRI scans.</AbstractText><AbstractText Label="INTERPRETATION">There are neuroimaging findings that are helpful in differentiating between myelitis associated with EV71, MOG, AQP4, and multiple sclerosis in children. These features may be useful early in the presentation of transverse myelitis while awaiting infectious/immunological testing, and/or further demyelinating events.</AbstractText><AbstractText Label="WHAT THIS PAPER ADDS">Magnetic resonance imaging can help identify aetiologies for children presenting with a first episode of myelitis. Entervirus-71-associated myelitis lesions are distributed throughout the cord and enhancement of nerve roots is common. Lesions distributed throughout the cord are commonly seen in myelin oligodendrocyte-associated myelitis. Aquaporin-4-associated myelitis lesions are distributed in the cervicothoracic spine, cavitation and contrast enhancing lesions are common. Short segment lesions in the cervicothoracic spine are commonly seen in multiple sclerosis-associated myelitis.</AbstractText><CopyrightInformation>&#xa9; 2018 Mac Keith Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tantsis</LastName><ForeName>Esther M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0003-3414-3889</Identifier><AffiliationInfo><Affiliation>Neuroimmunology Group, Institute for Neuroscience and Muscle Research, The Kids Research Institute, Children's Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Macquarie University, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prelog</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical Imaging Department, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alper</LastName><ForeName>Gulay</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinical Neuroimmunology Program, Division of Child Neurology Department of Paediatrics, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benson</LastName><ForeName>Leslie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorman</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Children's Neurosciences Centre, Evelina Children's Hospital, Newcomen Centre at St Thomas', St Thomas' Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammad</LastName><ForeName>Shekeeb S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Neuroimmunology Group, Institute for Neuroscience and Muscle Research, The Kids Research Institute, Children's Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Child and Adolescent Health, University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramanathan</LastName><ForeName>Sudarshini</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroimmunology Group, Institute for Neuroscience and Muscle Research, The Kids Research Institute, Children's Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brilot</LastName><ForeName>Fabienne</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroimmunology Group, Institute for Neuroscience and Muscle Research, The Kids Research Institute, Children's Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dale</LastName><ForeName>Russell C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0002-2495-1826</Identifier><AffiliationInfo><Affiliation>Neuroimmunology Group, Institute for Neuroscience and Muscle Research, The Kids Research Institute, Children's Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Child and Adolescent Health, University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>T.Y. Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Paediatric Myelitis Mri Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dev Med Child Neurol</MedlineTA><NlmUniqueID>0006761</NlmUniqueID><ISSNLinking>0012-1622</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051401">Aquaporin 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D063308">Myelin-Oligodendrocyte Glycoprotein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Dev Med Child Neurol. 2019 Sep;61(9):1001. doi: 10.1111/dmcn.14171</RefSource><PMID Version="1">30720201</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051401" MajorTopicYN="N">Aquaporin 4</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063308" MajorTopicYN="N">Myelin-Oligodendrocyte Glycoprotein</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009187" MajorTopicYN="N">Myelitis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>IM&#xc1;GENES DE RESONANCIA MAGN&#xc9;TICA EN ENTEROVIRUS-71, ANTICUERPOS DE GLICOPROTE&#xcd;NA DE LA MIELINA DEL OLIGODENDROCITO, ANTICUERPOS AQUAPORIN-4, Y ESCLEROSIS M&#xda;LTIPLE-ASOCIADA A MIELITIS EN NI&#xd1;OS: OBJETIVO: Utilizamos im&#xe1;genes de resonancia magn&#xe9;tica (IRM) para comparar la neuroimagen de los ni&#xf1;os con su primer episodio cl&#xed;nico de enterovirus 71-asociado a mielitis transversa (EV71-TM), mielitis transversa con anticuerpos de glicoprote&#xed;na de la mielina del oligodendrocito positivos (MOG-TM), mielitis transversa con anticuerpos aquaporin-4 positivos (AQP4-TM), mielitis transversa en esclerosis m&#xfa;ltiple (MS-TM) y mielitis transversa no clasificada (UNC-TM). M&#xc9;TODO: Se realiz&#xf3; un an&#xe1;lisis radiol&#xf3;gico, ciego, retrospectivo y se compar&#xf3; la neuroimagen de 52 ni&#xf1;os (32 mujeres, 20 varones; con edad promedio 9 a&#xf1;os 8 meses, La DS 5 a&#xf1;os 5 meses, el rango de 5 meses -17 a&#xf1;os) que presentaron su primer episodio de mielitis causada por EV71-TM (n= 11), MOG-TM (n= 10), AQP4-TM (n= 9), MS-TM (n= 13) y UNC-TM (n= 9). RESULTADOS: En el grupo de EV71-TM, fue com&#xfa;n observar lesiones distribuidas a trav&#xe9;s de la medula con realce de las ra&#xed;ces de nervio (ventrales y dorsales). El grupo de MOG-TM ten&#xed;a lesiones distribuidas a trav&#xe9;s de la m&#xe9;dula, m&#xe1;s com&#xfa;nmente mielitis transversa longitudinalmente extensa y lesiones que implican solamente la sustancia gris en exploraciones axiales. El grupo AQP4-TM ten&#xed;a lesiones distribuidas en la medula cervicodorsal, cavitaci&#xf3;n y lesiones con realce en el contraste. Todos Pacientes con AQP4-TM ten&#xed;an una IRM cerebral anormal. El grupo de MS-TM caracter&#xed;sticamente ten&#xed;a lesiones m&#xfa;ltiples de segmentos peque&#xf1;os de la medula que involucran las regiones cervical y dorsal. El grupo UNC-TM no ten&#xed;a hallazgos de IRM distintivos en la medula espinal, pero ten&#xed;a una relativa escasez de lesiones cerebrales IRM. INTERPRETACI&#xd3;N: Hay hallazgos de neuroimagen en ni&#xf1;os que son &#xfa;tiles en diferenciar entre mielitis asociada a EV71, a MOG, a AQP4, y esclerosis m&#xfa;ltiple. Estas caracter&#xed;sticas pueden ser &#xfa;tiles al inicio de la presentaci&#xf3;n de la mielitis transversa mientras se espera la prueba infecciosa/inmunol&#xf3;gica y/u otros acontecimientos desmielinizantes.</AbstractText><CopyrightInformation>&#xa9; 2018 Mac Keith Press.</CopyrightInformation></OtherAbstract><OtherAbstract Type="Publisher" Language="por"><AbstractText>IMAGEM POR RESSON&#xc2;NCIA MAGN&#xc9;TICA EM ENTEROV&#xcd;RUS-71, ANTICORPO DA GLICOPROTE&#xcd;NA DE OLIGODENDR&#xd3;CITO DA MIELINA, ANTICORPO AQUAPORINA-4, E MIELITE ASSOCIADA A ESCLEROSE M&#xda;LTIPLA EM CRIAN&#xc7;AS: OBJETIVO: Usamos imagens de resson&#xe2;ncia funcional (IRM) para comparar as neuroimagens de crian&#xe7;as com o primeiro epis&#xf3;sio de mielite transversa cl&#xed;nica associada a enterov&#xed;rus-71 (MT-EV71), mielite transversa positiva para anticorpo da glicoprote&#xed;na de oligodendr&#xf3;cit oda mielina (MT-GOM), mielite transversa positiva para anticorpo aquaporina-4 (MT-AQP4), mielite transversa em esclerose m&#xfa;ltipla (MT-EM), e mielite transversa n&#xe3;o classificada (MT-NC). M&#xc9;TODO: Realizamos uma avalia&#xe7;&#xe3;o radiol&#xf3;gica retrospectiva cega, e comparamos a neuroimagem de 52 crian&#xe7;as (32 do sexo feminino, 20 do sexo masculino; m&#xe9;dia de idade 9a 8m, DP 5a 5m, varia&#xe7;&#xe3;o 5m-17a) apresentando seu primeiro epis&#xf3;dio de mielite causada por MT-EV71 (n=11), MT-GOM (n=10), MT-AQP4 (n=9), MT-EM (n=13), e MT-NC (n=9). RESULTADOS: No grupo MT-EV71, as les&#xf5;es se distribu&#xed;ram por toda a medula, e realces das ra&#xed;zes nervosas (ventrais e dorsais) eram comuns. O grupo MT-GOM teve les&#xf5;es distribu&#xed;das por toda a medula, e mais comumente mielite transversa extensiva longitudinalmente e les&#xf5;es envolvendo apenas a subst&#xe2;ncia cinzenta nas imagens axiais. O grupo MT-AQP4 teve les&#xf5;es distribu&#xed;das na coluna c&#xe9;rvico-tor&#xe1;cica, cavita&#xe7;&#xe3;o, e les&#xf5;es real&#xe7;adas pelo contraste. Todos os pacientes com MT-AQP4 -tiveram uma IRM cerebral anormal. O grupo MT-EM caracteristicamente teve m&#xfa;ltiplas les&#xf5;es de segmentos curtos da medula envolvendo a regi&#xe3;o c&#xe9;rvico-tor&#xe1;cica. O grupo MT-NC n&#xe3;o teve achados distintivos de IRM espinhal, mas tiveram relativamente menos les&#xf5;es nas imagens cerebrais. INTERPRETA&#xc7;&#xc3;O: H&#xe1; achados de neuroimagem &#xfa;teis para diferenciar a mielite associada com EV71, GOM, AQP4 e esclerose m&#xfa;ltipla em crian&#xe7;as. Estes aspectos podem ser &#xfa;teis na apresenta&#xe7;&#xe3;o precoce da mielite transversa, enquanto se aguarda testes infecciosos/imunol&#xf3;gicos, e e/ou outros eventos desmielinizantes.</AbstractText><CopyrightInformation>&#xa9; 2018 Mac Keith Press.</CopyrightInformation></OtherAbstract><InvestigatorList><Investigator ValidYN="Y"><LastName>Antony</LastName><ForeName>Jayne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ardern-Holmes</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Banwell</LastName><ForeName>Brenda</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camposano</LastName><ForeName>Susana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gill</LastName><ForeName>Deepak</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hopkins</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menezes</LastName><ForeName>Manoj</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nosadini</LastName><ForeName>Margherita</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ouvrier</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Procopis</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riney</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Webster</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30537075</ArticleId><ArticleId IdType="doi">10.1111/dmcn.14114</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>